Bora CDMO Bora CDMO

X

Find Radio Compass News for Amphetamine Aspartate

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

left grey arrow
right gray arrow
  • CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-and-cediprof-announce-exclusive-distribution-agreement-in-us/articleshow/98508332.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
09 Mar 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215565

FDA
08 Jul 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210754

FDA
05 Jul 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214959

FDA
29 Sep 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213709

FDA
22 Apr 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-10-2020-1591766845.pdf

FDA
10 Jun 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212037

FDA
13 Dec 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2019-1571893469.pdf

FDA
24 Oct 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210080

FDA
20 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211546

FDA
27 Jun 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211715

FDA
20 May 2019

http://www.pharmabiz.com/NewsDetails.aspx?aid=115843&sid=2

PHARMABIZ
16 May 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211547

FDA
24 Apr 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205401

FDA
26 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211352

FDA
10 Dec 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205401

FDA
30 Nov 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210080

FDA
15 Nov 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210080

FDA
03 Nov 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209799

FDA
30 Dec 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207340

FDA
02 Nov 2017

https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-mydayis-amphetamine-aspartateamphetamine-sulfatedextroamphetamine-saccharatedextroamphetamine-sulfate-extended-release-capsules-1509424451.pdf

FDA
30 Oct 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207388

FDA
31 Jul 2017

https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-13apr2016-1460549225.pdf

FDA
12 Apr 2016

http://www.prnewswire.com/news-releases/impax-receives-fda-approval-for-generic-version-of-adderall-xr-mixed-salts-of-a-single-entity-amphetamine-product-capsules-cii-300221210.html

PR NEWSWIRE
17 Feb 2016

https://www.pharmacompass.com/pdf/news/actavis-elizabeths-generic-dextroamp-saccharatesulfateamp-aspartatesulfate-approved-in-us-1455706106.pdf

FDA
05 Feb 2016

http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0566-2016&w=01202016&lang=eng

FDA
20 Jan 2016

http://www.prnewswire.com/news-releases/mylan-launches-generic-adderall-tablets-300182073.html

PR NEWS WIRE
19 Nov 2015

https://www.pharmacompass.com/pdf/news/mylan-generic-dextroamp-saccharatesulfateamp-aspartatesulfate-approved-in-us-1447760130.pdf

FDA
14 Nov 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY